Fortinet Deal a Nod, Not the Foundry Proof Intel Still Needs

What happened

Intel announced it will manufacture Fortinet's next-generation Security Processor 6, a design win on its mature Intel 4 node, adding a cybersecurity name to its foundry client list. The master report flagged this as a credibility boost but noted the real commercial question centers on leading-edge 18A and 14A nodes, not mature processes. External foundry revenue remains at just $293 million quarterly, or about 5% of segment sales, with nearly all foundry activity still supporting internal manufacturing. Intel's own 10-K warns that failing to land a significant 14A customer could force a node pause or discontinuation, so mature-node wins don't mitigate that risk. The stock already prices in strong product recovery and foundry optimism, leaving limited upside from incremental, non‑leading‑edge deals.

Implication

The Fortinet win provides a minor credibility lift, but it uses Intel 4, not the 18A or 14A nodes that underpin the bullish foundry thesis. External foundry revenue remains sub‑$300 million quarterly, while the stock price already discounts successful commercialization that management has yet to prove. Without a named 18A or 14A customer by mid‑2027, Intel’s own disclosures suggest a possible roadmap reset, which would undermine the capital‑intensive foundry strategy. Investors should focus on announcements of leading‑edge wins rather than mature‑node pickups, as only those will close the gap between product recovery and foundry monetization. For now, the existing WAIT rating and attractive entry around $85 remain intact, with the $100+ level still requiring more substantial foundry proof.

Thesis delta

The Fortinet deal adds a new external client but does not shift the core thesis, as it uses a mature node and doesn't address the critical need for leading‑edge 18A or 14A customer validation. The stock remains priced for a recovery that has yet to deliver commercial foundry proof beyond internal manufacturing improvements. As a result, the investment case is unchanged, and the WAIT rating holds.